Prophylactic methylxanthine for prevention of apnea in preterm infants

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Henderson Smart, David J ^a   Steer, Peter A ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apnea *prevention control ; Central nervous system stimulants *therapeutic use ; Infant, newborn; Infant, premature; Infant, premature, diseases *prevention control ; Xanthines *therapeutic use

Indexed keywords

CAFFEINE; CAFFEINE CITRATE; METHYLXANTHINE; PLACEBO;

APNEA; ARTIFICIAL VENTILATION; BRADYCARDIA; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; FEEDING DISORDER; GESTATIONAL AGE; GROWTH DISORDER; HUMAN; HYPONATREMIA; HYPOXEMIA; INTERMITTENT POSITIVE PRESSURE VENTILATION; LOADING DRUG DOSE; MORBIDITY; NEWBORN MORBIDITY; OUTCOME ASSESSMENT; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; TACHYCARDIA; TREATMENT DURATION; TREATMENT INDICATION;

EID: 77950174367     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000432     Document Type: Review

References (16)

1. Bucher 1988 {published and unpublished data} Bucher HU, Duc G. Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial. European Journal of Pediatrics 1988;147:288-91.
2. Levitt 1988 {published and unpublished data} Levitt GA, Harvey DR. The use of prophylactic caffeine in the prevention of neonatal apnoeic attacks.. Unpublished manuscript. Levitt GA, Mushin A, Bellman S, Harvey DR. Outcome of preterm infants who suffered neonatal apnoeic attacks. Early Human Development 1988;16:235-43.
3. Larsen 1995 {published data only} Larsen PB, Brendstrup L, Skov L, Flachs H. Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates. Acta Paediatrica 1995;84:360-4.
4. CAP Trial 2006 {published data only} Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W, Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. New England Journal of Medicine 2006;354(20):2112-21.
5. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W, Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. New England Journal of Medicine 2007;357(19): 1893-902.
6. AAP 2003 American Academy of Pediatrics. Policy statement. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003; 111:914-22.
7. Blanchard 1992 Blanchard PW, Aranda JV. Pharmacotherapy of respiratory control disorders. In: Beckerman RC, Brouillette RT, Hunt CE editor(s). Respiratory Control Disorders in Infants and Children. Baltimore: Williams & Wilkins, 1992:352-70.
8. Finer 2006 Finer NN, Higgins R, Kattwinkel J, Martin RJ. Summary proceedings from the apnea-of-prematurity group. Pediatrics 2006; 117 Pt 2:S47-51.
9. Henderson-Smart 1995 Henderson-Smart DJ. Recurrent apnea. In: Yu VYH editor(s). Bailliere's Clinical Paediatrics. Vol. 3, No. 1 Pulmonary Problems in the Perinatal Period and their Sequelae, London: Bailliere Tindall, 1995:203-22.
10. Henderson-Smart 2008a Henderson-Smart DJ, Davis PG. Prophylactic methylxanthine for extubation in preterm infants. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD000139]
11. Henderson-Smart 2008b Henderson-Smart DJ, Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD000140]
12. Samuels 1992 Samuels MP, Southall DP. Recurrent Apnea. In: Sinclair JC, Bracken MB editor(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992:385-97.
13. Steer 2005 Steer P, Henderson-Smart DJ. Caffeine vs theophylline treatment for apnea in preterm infants. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD000273]
14. Henderson-Smart 1999 Henderson-Smart DJ, Steer PA. Prophylactic methylxanthine for prevention of apnea in preterm infants. Cochrane Database of Systematic Reviews 1999, Issue 2. [DOI: 10.1002/14651858.CD000432]
15. Henderson-Smart 2002 Henderson-Smart DJ, Steer PA. Prophylactic methylxanthine for prevention of apnea in preterm infants. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD000432]
16. Henderson-Smart 2006 Henderson-Smart DJ, Steer PA . Cochrane Database of Systematic Reviews. Prophylactic methylxanthine for prevention of apnea in preterm infants. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD000432]